Intestinal organoids for assessing nutrient transport, sensing and incretin secretion

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zietek, Tamara ^a   Rath, Eva ^a   Haller, Dirk ^a   Daniel, Hannelore ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2',7'-BIS-(2-CARBOXYETHYL)-5(6)-CARBOXYFLUORESCEIN ACETOXYMETHYL ESTER; ACID; CALCIUM; DRUG; FLUORESCEIN DERIVATIVE; FURA 2; FURA-2-AM; INCRETIN;

ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CELL SURVIVAL; CYTOPLASM; FLUORESCENCE; FOOD; INTESTINE; INTRACELLULAR SPACE; METABOLISM; MOLECULAR IMAGING; REPRODUCIBILITY; SECRETION (PROCESS); SMALL INTESTINE; TRANSPORT AT THE CELLULAR LEVEL;

ACIDS; ANIMALS; BIOLOGICAL TRANSPORT; CALCIUM; CELL SURVIVAL; FLUORESCEINS; FLUORESCENCE; FOOD; FURA-2; INCRETINS; INTESTINE, SMALL; INTESTINES; INTRACELLULAR SPACE; MICE, INBRED C57BL; MOLECULAR IMAGING; ORGANOIDS; PHARMACEUTICAL PREPARATIONS; REPRODUCIBILITY OF RESULTS;

EID: 84947558943     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16831     Document Type: Article

References (39)

1. Janssen, S. & Depoortere, I. Nutrient sensing in the gut: new roads to therapeutics? Trends Endocrinol. Metab. 24, 92-100 (2013).
2. Breen, D. M., Rasmussen, B. A., Cote, C. D., Jackson, V. M. & Lam, T. K. Nutrient-sensing mechanisms in the gut as therapeutic targets for diabetes. Diabetes 62, 3005-3013 (2013).
3. Breen, D. M. et al. Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. Nat. Med. 18, 950-955 (2012).
4. Efeyan, A., Comb, W. C. & Sabatini, D. M. Nutrient-sensing mechanisms and pathways. Nature 517, 302-310 (2015).
5. Mudaliar, S. & Henry, R. R. The incretin hormones: from scientific discovery to practical therapeutics. Diabetologia 55, 1865-1868 (2012).
6. Egerod, K. L. et al. A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin. Endocrinology 153, 5782-5795 (2012).
7. Habib, A. M. et al. Overlap of endocrine hormone expression in the mouse intestine revealed by transcriptional profiling and flow cytometry. Endocrinology 153, 3054-3065 (2012).
8. Reimann, F. et al. Glucose sensing in L cells: a primary cell study. Cell Metab. 8, 532-539 (2008).
9. Stelzner, M. et al. A nomenclature for intestinal in vitro cultures. Am. J. Physiol. Gastrointest. Liver Physiol. 302, 1359-1363 (2012).
10. Sato, T. et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459, 262-265 (2009).
11. Spence, J. R. et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470, 105-109 (2011).
12. Petersen, N. et al. Targeting development of incretin-producing cells increases insulin secretion. J. Clin. Invest. 125, 379-385 (2015).
13. Yui, S. et al. Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5(+ ) stem cell. Nat. Med. 18, 618-623 (2012).
14. Li, V. S. & Clevers, H. In vitro expansion and transplantation of intestinal crypt stem cells. Gastroenterology 143, 30-34 (2012).
15. Koo, B. K. et al. Controlled gene expression in primary Lgr5 organoid cultures. Nat. Methods 9, 81-83 (2012).
16. Thorens, B. & Mueckler, M. Glucose transporters in the 21st Century. Am. J. Physiol. Endocrinol. Metab. 298, 141-145 (2010).
17. Roder, P. V. et al. The role of SGLT1 and GLUT2 in intestinal glucose transport and sensing. PLoS One 9, e89977 (2014).
18. Sugano, K. et al. Coexistence of passive and carrier-mediated processes in drug transport. Nat. Rev. Drug Discov. 9, 597-614 (2010).
19. Berthelsen, R., Nielsen, C. U. & Brodin, B. Basolateral glycylsarcosine (Gly-Sar) transport in Caco-2 cell monolayers is pH dependent. J. Pharm. Pharmacol. 65, 970-979 (2013).
20. Diakogiannaki, E. et al. Oligopeptides stimulate glucagon-like peptide-1 secretion in mice through proton-coupled uptake and the calcium-sensing receptor. Diabetologia 56, 2688-2696 (2013).
21. Gorboulev, V. et al. Na(+ )-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes 61, 187-196 (2012).
22. Parker, H. E. et al. Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion. Br. J. Pharmacol. 165, 414-423 (2012).
23. Thomas, C. et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 10, 167-177 (2009).
24. Watterson, K. R., Hudson, B. D., Ulven, T. & Milligan, G. Treatment of type 2 diabetes by free Fatty Acid receptor agonists. Front. Endocrinol. (Lausanne) 5, 137 (2014).
25. Petersen, N. et al. Generation of L cells in mouse and human small intestine organoids. Diabetes 63, 410-420 (2014).
26. Middendorp, S. et al. Adult stem cells in the small intestine are intrinsically programmed with their location-specific function. Stem Cells 32, 1083-1091 (2014).
27. Zietek, T. & Daniel, H. Intestinal nutrient sensing and blood glucose control. Curr. Opin. Clin. Nutr. Metab. Care 18, 381-388 (2015).
28. Daniel, H. & Zietek, T. Taste and move: Glucose and peptide transporters in the gastrointestinal tract. Exp. Physiol., doi: 10.1113/EP085029 (2015).
29. Wenzel, U., Kuntz, S., Diestel, S. & Daniel, H. PEPT1-mediated cefixime uptake into human intestinal epithelial cells is increased by Ca2+ channel blockers. Antimicrob. Agents Chemother. 46, 1375-1380 (2002).
30. Kellett, G. L., Brot-Laroche, E., Mace, O. J. & Leturque, A. Sugar absorption in the intestine: the role of GLUT2. Annu. Rev. Nutr. 28, 35-54 (2008).
31. Buzzi, N., Bilbao, P. S., Boland, R. & de Boland & A. R. Extracellular ATP activates MAP kinase cascades through a P2Y purinergic receptor in the human intestinal Caco-2 cell line. Biochim. Biophys. Acta 1790, 1651-1659 (2009).
32. Dong, X. et al. P2Y receptors mediate Ca2+ signaling in duodenocytes and contribute to duodenal mucosal bicarbonate secretion. Am. J. Physiol. Gastrointest. Liver Physiol. 296, 424-432 (2009).
33. Burnstock, G. Purinergic signalling in the gastrointestinal tract and related organs in health and disease. Purinergic Signal. 10, 3-50 (2014).
34. Chen, M. et al. Gene ablation for PEPT1 in mice abolishes the effects of dipeptides on small intestinal fluid absorption, shortcircuit current, and intracellular pH. Am. J. Physiol. Gastrointest. Liver Physiol. 299, 265-274 (2010).
35. Govindan, S. & Taylor, C. W. P2Y receptor subtypes evoke different Ca2+ signals in cultured aortic smooth muscle cells. Purinergic Signal. 8, 763-777 (2012).
36. James, G. & Butt, A. M. P2X and P2Y purinoreceptors mediate ATP-evoked calcium signalling in optic nerve glia in situ. Cell Calcium 30, 251-259 (2001).
37. VanDussen, K. L. et al. Development of an enhanced human gastrointestinal epithelial culture system to facilitate patient-based assays. Gut 64, 911-920 (2015).
38. Hu, Y. et al. Targeted disruption of peptide transporter Pept1 gene in mice significantly reduces dipeptide absorption in intestine. Mol. Pharm. 5, 1122-1130 (2008).
39. Wu, X. et al. Glucose transporter 5 is undetectable in outer hair cells and does not contribute to cochlear amplification. Brain Res. 1210, 20-28 (2008).